Sotalol: Difference between revisions
(Created page with "== Adult Dosing == *80mg PO BID == Indications == *Suppression of ventricular arrhythmias refractory to other meds *Suppression of SVT, a-fib == Mechanism of Action == *Class I...") |
No edit summary |
||
| Line 1: | Line 1: | ||
== Adult Dosing == | ==General== | ||
*Type: [[Beta blockers]] | |||
*Dosage Forms: | |||
*Common Trade Names: | |||
==Adult Dosing== | |||
*80mg PO BID | *80mg PO BID | ||
==Pediatric Dosing== | |||
==Special Populations== | |||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | |||
*Lactation: | |||
*Renal Dosing | |||
**Adult | |||
**Pediatric | |||
*Hepatic Dosing | |||
**Adult | |||
**Pediatric | |||
== Indications == | == Indications == | ||
| Line 6: | Line 23: | ||
*Suppression of SVT, a-fib | *Suppression of SVT, a-fib | ||
== | ==Contraindications== | ||
* | *Allergy to class/drug | ||
== Adverse | ==Adverse Reactions== | ||
*Hypotension, bradycardia | *Hypotension, bradycardia | ||
*Proarrhythmia (esp in | *Proarrhythmia (esp in patients with [[hypokalemia]]) | ||
== | ==Pharmacology== | ||
*Half-life: | |||
*Metabolism: | |||
*Excretion: | |||
*Mechanism of Action: | |||
**Class II - Nonselective beta-blocker | |||
**Class III effects (prolongs repol and refractoriness) | |||
*Onset of action = 2-3hr | *Onset of action = 2-3hr | ||
*Duration of action = 24hr | *Duration of action = 24hr | ||
==See Also== | ==See Also== | ||
[[Antiarrhythmics]] | *[[Antiarrhythmics]] | ||
==Sources== | |||
<references/> | |||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 18:51, 8 March 2015
General
- Type: Beta blockers
- Dosage Forms:
- Common Trade Names:
Adult Dosing
- 80mg PO BID
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Indications
- Suppression of ventricular arrhythmias refractory to other meds
- Suppression of SVT, a-fib
Contraindications
- Allergy to class/drug
Adverse Reactions
- Hypotension, bradycardia
- Proarrhythmia (esp in patients with hypokalemia)
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
- Class II - Nonselective beta-blocker
- Class III effects (prolongs repol and refractoriness)
- Onset of action = 2-3hr
- Duration of action = 24hr